Overview
Congenital isolated ACTH deficiency (IAD) is a rare endocrine disorder characterized by a selective deficiency of adrenocorticotropic hormone (ACTH) secretion from the anterior pituitary gland, while other pituitary hormones remain normally produced. ACTH is essential for stimulating the adrenal glands to produce cortisol, a hormone critical for stress response, blood sugar regulation, immune function, and blood pressure maintenance. Without adequate ACTH, the adrenal glands fail to produce sufficient cortisol, leading to secondary adrenal insufficiency. Clinical features typically present in the neonatal period or early infancy and can include severe hypoglycemia (low blood sugar), prolonged neonatal jaundice (particularly cholestatic jaundice), seizures due to hypoglycemia, failure to thrive, and recurrent infections. In some cases, adrenal crisis can occur, which is a life-threatening emergency characterized by profound hypotension, dehydration, and shock, particularly during physiological stress such as illness or surgery. Unlike primary adrenal insufficiency, skin hyperpigmentation is absent because ACTH levels are low rather than elevated. Congenital isolated ACTH deficiency can be caused by mutations in the TBX19 gene (also known as TPIT), which encodes a transcription factor essential for the differentiation of pituitary corticotroph cells. Mutations in this gene account for a significant proportion of neonatal-onset cases and follow an autosomal recessive inheritance pattern. Some cases may also be associated with mutations in the POMC gene (proopiomelanocortin), which can present with ACTH deficiency alongside obesity and red hair pigmentation. Treatment consists of lifelong glucocorticoid replacement therapy, typically with hydrocortisone, with dose adjustments during periods of physiological stress. Early diagnosis and prompt treatment are critical to prevent life-threatening hypoglycemia and adrenal crises, and with appropriate management, patients can lead relatively normal lives.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital isolated ACTH deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital isolated ACTH deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital isolated ACTH deficiency.
Community
No community posts yet. Be the first to share your experience with Congenital isolated ACTH deficiency.
Start the conversation →Latest news about Congenital isolated ACTH deficiency
No recent news articles for Congenital isolated ACTH deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital isolated ACTH deficiency
What is Congenital isolated ACTH deficiency?
Congenital isolated ACTH deficiency (IAD) is a rare endocrine disorder characterized by a selective deficiency of adrenocorticotropic hormone (ACTH) secretion from the anterior pituitary gland, while other pituitary hormones remain normally produced. ACTH is essential for stimulating the adrenal glands to produce cortisol, a hormone critical for stress response, blood sugar regulation, immune function, and blood pressure maintenance. Without adequate ACTH, the adrenal glands fail to produce sufficient cortisol, leading to secondary adrenal insufficiency. Clinical features typically present in
How is Congenital isolated ACTH deficiency inherited?
Congenital isolated ACTH deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital isolated ACTH deficiency typically begin?
Typical onset of Congenital isolated ACTH deficiency is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital isolated ACTH deficiency?
10 specialists and care centers treating Congenital isolated ACTH deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.